article thumbnail

Indian medical devices cos to invest in innovation for products minimizing environmental footprint

AuroBlog - Aurous Healthcare Clinical Trials blog

Indian medical devices companies are increasingly looking to invest in innovation for developing products that help to minimize environmental footprint.

article thumbnail

Opinion: Where are the guidelines for the production of animals with intentional genomic alterations?

STAT News

Genetic engineering has the potential to transform how we raise animals for meat and other products, making food safer, improving animal health and welfare, and shrinking animal agriculture’s environmental footprint. Pigs that are less likely to induce allergic reactions in humans. Read the rest…

Genome 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New era of genomic medicine begins as UK approves Lilly’s Retsevmo

pharmaphorum

The UK regulator has authorised Eli Lilly’s targeted cancer drug Retsevmo for tumours with RET fusion positive lung cancers and thyroid cancers, which the company said could herald a new era of genomic medicine for the NHS. The post New era of genomic medicine begins as UK approves Lilly’s Retsevmo appeared first on.

Genome 111
article thumbnail

The use of genomic profiling testing to improve oncology care

pharmaphorum

This reach allows us to support 82% of the novel drugs and therapeutic products approved by the US FDA, including 63% of those specific to oncology,” Reddy states. The test informs HCPs through a comprehensive genomic and immune profiling test clinically and analytically validated for all solid tumours. Navigating barriers to access.

Genomics 105
article thumbnail

Sangamo’s cell therapy receives EC orphan medicinal product designation

Pharmaceutical Technology

Sangamo Therapeutics has received orphan medicinal product designation (OMPD) from the European Commission (EC) for its Investigational autologous Chimeric Antigen Receptor Regulatory T Cell (CAR-Treg) cell therapy, TX200, for solid organ transplantation.

Medicine 130
article thumbnail

Genome Edited Foods: Understanding the New FDA Guidance

XTalks

In a pivotal move for the food industry, the US Food and Drug Administration (FDA) has unveiled industry guidance for genome edited foods derived from plants. This landmark guidance aims to demystify the FDA’s risk-based approach towards both genome edited foods and all new plant varieties. What is Genome Editing?

Genome 86
article thumbnail

Roche launches Foundation Medicine-partnered genomic profiling kit

Pharma Times

Product designed to allow laboratories to expand in-house oncology research

Genome 129